University of Texas Southwestern Medical Center in Dallas
While semaglutide starts working soon after you take it, you wont see results immediately
In the SUSTAIN 6 trial, over 3,297 patients with type 2 diabetes with established chronic kidney disease and/or cardiovascular disease underwent randomization to semaglutide or placebo and were followed for 2 years resulting in a 26% risk reduction in the combined endpoint of rate of cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke [47]
Chronic Pancreatitis
Foundayo side effects at the highest dose include the following: nausea (35%), diarrhea (25%), constipation (24%), vomiting (24%), and stomach upset (13%)
Adults without diabetes saw average weight loss of 15% to 20.9% depending on dosage, compared to 3.1% for people on a placebo